GlassScriptPhysician profile
Dustin A Smith
NPI 1417443995
$4,800.11
in general payments reported to CMS, 2019-2025
37 companies · $893 in 2025
The $893 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $734 · 2022: $1,395 · 2023: $1,199 · 2024: $578 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,013 · Travel and Lodging: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,012.77 |
| Travel and Lodging | $657.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,096.49 | 2021-2025 | |
| Spinal Simplicity, LLC | $993.06 | 2022 | |
| Medtronic, INC. | $754.81 | 2023 | Synchromedii |
| Abbott Laboratories | $301.48 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Freestyle Libre 3 |
| Amgen INC. | $252.60 | 2023-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $123.00 | 2021-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $102.29 | 2021-2024 | Jardiance, Emgality, Zepbound |
| Astellas Pharma US INC | $95.49 | 2021-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $89.88 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $74.88 | 2023-2024 | Shingrix, Bexsero, Arexvy |
| Aimmune Therapeutics, INC. | $74.41 | 2024-2025 | Zenpep |
| Pfizer INC. | $69.20 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $62.77 | 2024-2025 | Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.74 | 2025 | Xifaxan |
| Xeris Pharmaceuticals, INC. | $55.65 | 2022-2025 | Gvoke Hypopen |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.